Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

T follicular helper cells in the humoral immune response to SARS-CoV-2 infection and vaccination
Marios Koutsakos, Wen Shi Lee, Adam K. Wheatley, et al.
Journal of Leukocyte Biology (2021) Vol. 111, Iss. 2, pp. 355-365
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine
Jana Sophia Buhre, Tamás Pongrácz, Inga Künsting, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 63
Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults
Hassen Kared, Asia‐Sophia Wolf, Amin Alirezaylavasani, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 59
Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory
Kathleen M. Wragg, Wen Shi Lee, Marios Koutsakos, et al.
Nature Immunology (2022) Vol. 23, Iss. 5, pp. 768-780
Open Access | Times Cited: 55
The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants
Marios Koutsakos, Wen Shi Lee, Arnold Reynaldi, et al.
Immunity (2022) Vol. 55, Iss. 7, pp. 1316-1326.e4
Open Access | Times Cited: 53
SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines
Raju Sunagar, Amit Kumar Singh, Sudeep Kumar
Vaccines (2023) Vol. 11, Iss. 4, pp. 849-849
Open Access | Times Cited: 23
Destabilisation of T cell-dependent humoral immunity in sepsis
Kate Davies, James E. McLaren
Clinical Science (2024) Vol. 138, Iss. 1, pp. 65-85
Open Access | Times Cited: 6
SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies
Zhongfang Wang, Xiaoyun Yang, Xinyue Mei, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 26
Safety and Immunogenicity of Inactivated COVID-19 Vaccines Among People Living with HIV in China
Xiaoxu Han, Xiaobo Yu, Ying Han, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 2091-2100
Open Access | Times Cited: 21
Memory B Cells and Memory T Cells Induced by SARS-CoV-2 Booster Vaccination or Infection Show Different Dynamics and Responsiveness to the Omicron Variant
Setsuko Mise‐Omata, Mari Ikeda, Masaru Takeshita, et al.
The Journal of Immunology (2022) Vol. 209, Iss. 11, pp. 2104-2113
Open Access | Times Cited: 19
Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects
Vivian Glück, Leonid Tydykov, Anna-Lena Mader, et al.
Infection (2022) Vol. 50, Iss. 6, pp. 1475-1481
Open Access | Times Cited: 17
Low pre-existing endemic human coronavirus (HCoV-NL63)-specific T cell frequencies are associated with impaired SARS-CoV-2-specific T cell responses in people living with HIV
Tiza L. Ng’uni, Vernon Musale, Thandeka Nkosi, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 2
High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infection
Hitoshi Kawasuji, Yoshitomo Morinaga, Kentaro Nagaoka, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Antigen-specific T helper cells and cytokine profiles predict intensity and longevity of cellular and humoral responses to SARS-CoV-2 booster vaccination
Lukas Page, Kevin M. Dennehy, Katharina Mueller, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Where do T cell subsets stand in SARS-CoV-2 infection: an update
Mohammad Tarique, Mohd Suhail, Huma Naz, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 11
Plasmablasts in previously immunologically naïve COVID-19 patients express markers indicating mucosal homing and secrete antibodies cross-reacting with SARS-CoV-2 variants and other beta-coronaviruses
Anna Karin Lundgren, Susannah Leach, Hannes Axelsson, et al.
Clinical & Experimental Immunology (2023) Vol. 213, Iss. 2, pp. 173-189
Open Access | Times Cited: 5
T cell responses to SARS-CoV-2 in humans and animals
Sameer-ul-Salam Mattoo, Jinjong Myoung
The Journal of Microbiology (2022) Vol. 60, Iss. 3, pp. 276-289
Open Access | Times Cited: 9
A Pilot Trial of Thymalfasin (Thymosin-α-1) to Treat Hospitalized Patients With Hypoxemia and Lymphocytopenia Due to Coronavirus Disease 2019 Infection
Fadi Shehadeh, Gregorio Benitez, Evangelia K. Mylona, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 2, pp. 226-235
Open Access | Times Cited: 9
A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV
Zhengchao Lv, Songqin Lv, Qin Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
A Promising Vaccination Strategy against COVID-19 on the Horizon: Heterologous Immunization
Sameer-ul-Salam Mattoo, Jinjong Myoung
Journal of Microbiology and Biotechnology (2021) Vol. 31, Iss. 12, pp. 1601-1614
Open Access | Times Cited: 10
T helper cell subsets and related target cells in acute COVID-19
I. V. Kudryavtsev, А. С. Головкин, Арег А. Тотолян
Russian Journal of Infection and Immunity (2022) Vol. 12, Iss. 3, pp. 409-426
Open Access | Times Cited: 6
Early CD4+ T cell responses induced by the BNT162b2 SARS-CoV-2 mRNA vaccine predict immunological memory
Jie Bai, Asako Chiba, Goh Murayama, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Antigen-Specific CD4 T Cell and B Cell Responses to Borrelia burgdorferi
Elizabeth M. Hammond, Kimberly J. Olsen, Shivneel Ram, et al.
The Journal of Immunology (2023) Vol. 211, Iss. 6, pp. 994-1005
Closed Access | Times Cited: 3
Broad-Spectrum Heavily Mutated Monoclonal Antibody Isolated from COVID-19 Convalescent Vaccinee with Capacity to Neutralize SARS-CoV2 Variants Ranging from B.1 to BQ.1.1
Alok Choudhary, David Calianese, William Honnen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Immune responses to SARS-CoV-2 mRNA vaccination in people with idiopathic CD4 lymphopenia
Joseph M. Rocco, Kristin L. Boswell, Elizabeth Laidlaw, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 153, Iss. 2, pp. 503-512
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top